Vicus Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.2M Sell
4,894
-76
-2% -$17.7K 0.09% 110
2025
Q4
$1.03M Sell
4,970
-1,235
-20% -$244K 0.08% 111
2025
Q3
$1.15M Buy
6,205
+1,129
+22% +$193K 0.09% 105
2025
Q2
$775K Sell
5,076
-8
-0.2% -$1.23K 0.06% 110
2025
Q1
$843K Sell
5,084
-380
-7% -$59.5K 0.08% 98
2024
Q4
$790K Buy
5,464
+104
+2% +$16.1K 0.07% 104
2024
Q3
$869K Sell
5,360
-1,510
-22% -$241K 0.08% 102
2024
Q2
$1M Sell
6,870
-206
-3% -$30.6K 0.09% 101
2024
Q1
$1.12M Buy
7,076
+856
+14% +$136K 0.1% 91
2023
Q4
$975K Sell
6,220
-1,653
-21% -$253K 0.1% 89
2023
Q3
$1.23M Buy
7,873
+1,721
+28% +$284K 0.13% 80
2023
Q2
$1.02M Sell
6,152
-394
-6% -$63.6K 0.11% 87
2023
Q1
$1.01M Sell
6,546
-219
-3% -$35.4K 0.11% 88
2022
Q4
$1.2M Sell
6,765
-6,180
-48% -$1.07M 0.14% 82
2022
Q3
$2.12M Buy
12,945
+5,372
+71% +$909K 0.25% 55
2022
Q2
$1.34M Buy
7,573
+903
+14% +$161K 0.15% 85
2022
Q1
$1.18M Buy
6,670
+72
+1% +$12.3K 0.12% 94
2021
Q4
$1.14M Buy
+6,598
New +$1.08M 0.12% 97
2021
Q2
Sell
-7,911
Closed -$1.3M 200
2021
Q1
$1.3M Buy
7,911
+480
+6% +$77.7K 0.15% 77
2020
Q4
$1.17M Sell
7,431
-124
-2% -$18.3K 0.14% 75
2020
Q3
$1.13M Sell
7,555
-326
-4% -$48.2K 0.16% 70
2020
Q2
$1.11M Sell
7,881
-271
-3% -$39.5K 0.17% 72
2020
Q1
$1.07M Sell
8,152
-849
-9% -$120K 0.2% 69
2019
Q4
$1.31M Sell
9,001
-5,966
-40% -$809K 0.2% 67
2019
Q3
$1.94M Sell
14,967
-182
-1% -$24K 0.27% 65
2019
Q2
$2.11M Buy
15,149
+244
+2% +$33.8K 0.3% 61
2019
Q1
$2.08M Buy
14,905
+582
+4% +$78K 0.33% 53
2018
Q4
$1.85M Sell
14,323
-10
-0.1% -$1.4K 0.33% 58
2018
Q3
$1.98M Sell
14,333
-175
-1% -$23.3K 0.32% 53
2018
Q2
$1.76M Sell
14,508
-642
-4% -$80.1K 0.29% 60
2018
Q1
$1.94M Sell
15,150
-2,138
-12% -$289K 0.34% 54
2017
Q4
$2.42M Sell
17,288
-903
-5% -$126K 0.42% 43
2017
Q3
$2.37M Sell
18,191
-145
-0.8% -$19.2K 0.46% 45
2017
Q2
$2.43M Buy
18,336
+463
+3% +$59.1K 0.5% 42
2017
Q1
$2.23M Sell
17,873
-1,966
-10% -$235K 0.48% 46
2016
Q4
$2.29M Buy
19,839
+1,772
+10% +$205K 0.51% 45
2016
Q3
$2.13M Buy
18,067
+548
+3% +$66.5K 0.49% 56
2016
Q2
$2.13M Buy
17,519
+479
+3% +$54.4K 0.52% 48
2016
Q1
$1.84M Buy
17,040
+292
+2% +$30.2K 0.42% 52
2015
Q4
$1.72M Buy
16,748
+2,072
+14% +$208K 0.44% 62
2015
Q3
$1.37M Buy
14,676
+3,595
+32% +$348K 0.36% 64
2015
Q2
$1.08M Sell
11,081
-202
-2% -$20.2K 0.28% 79
2015
Q1
$1.14K Buy
11,283
+107
+1% +$10.9K 0.22% 74
2014
Q4
$1.17M Sell
11,176
-213
-2% -$22.4K 0.34% 67
2014
Q3
$1.21M Buy
11,389
+1,660
+17% +$172K 0.4% 49
2014
Q2
$1.02M Buy
9,729
+243
+3% +$24.6K 0.33% 58
2014
Q1
$932K Buy
9,486
+1,406
+17% +$130K 0.32% 63
2013
Q4
$740K Buy
+8,080
New +$745K 0.28% 59

Other funds holding JNJ

Vicus Capital's JNJ Position: Q1 2026 in Review

Vicus Capital reduced its Johnson & Johnson (JNJ) stake by 1.5% in Q1 2026, selling an estimated $17.7K and leaving 4,894 shares worth $1.2M. The position accounts for 0.09% of the portfolio, ranked #110.

Vicus Capital first reported a position in JNJ in Q4 2013 and has held it in 48 quarters since. The position peaked at $2.43M in Q2 2017. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Vicus Capital held 4,894 shares of Johnson & Johnson worth $1.2M as of Q1 2026.
  • Vicus Capital sold 76 Johnson & Johnson shares in Q1 2026, an estimated $17.7K.
  • Johnson & Johnson made up 0.09% of Vicus Capital's portfolio in Q1 2026, its #110 holding.
  • Vicus Capital first reported a position in Johnson & Johnson in Q4 2013 and has held it in 48 quarters since.
  • Vicus Capital's Johnson & Johnson position peaked at $2.43M in Q2 2017.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Vicus Capital's 13F filing for Q1 2026, filed 22 Apr 2026.